HOLX Hologic Inc
Price (delayed)
$64.49
Market cap
$14.47B
P/E Ratio
20.22
Dividend/share
N/A
EPS
$3.19
Enterprise value
$15.23B
Hologic, Inc. is a medical technology company primarily focused on women’s health; it sells medical devices for diagnostics, surgery, and medical imaging. In late November 2013, activist investor Carl Icahn
Highlights
The stock's price to earnings (P/E) is 28% less than its last 4 quarters average of 28.0 and 4.6% less than its 5-year quarterly average of 21.2
The gross profit has grown by 11% YoY
The EPS has surged by 50% year-on-year but it has declined by 4.8% since the previous quarter
Hologic's net income has increased by 44% YoY but it has decreased by 6% QoQ
Hologic's quick ratio has decreased by 10% YoY and by 8% QoQ
Key stats
What are the main financial stats of HOLX
Market
Valuations
Earnings
Shares outstanding
224.39M
Market cap
$14.47B
Enterprise value
$15.23B
Price to earnings (P/E)
20.22
Price to book (P/B)
3.07
Price to sales (P/S)
3.68
EV/EBIT
14.53
EV/EBITDA
11.34
EV/Sales
3.77
Revenue
$4.04B
Gross profit
$2.24B
Operating income
$914.2M
Net income
$744M
EBIT
$1.05B
EBITDA
$1.34B
Free cash flow
$1.12B
Per share
Balance sheet
Liquidity
EPS
$3.19
EPS diluted
$3.16
Free cash flow per share
$4.87
Book value per share
$21.03
Revenue per share
$17.54
TBVPS
$19.6
Total assets
$8.73B
Total liabilities
$3.96B
Debt
$2.54B
Equity
$4.77B
Working capital
$2.49B
Debt to equity
0.53
Current ratio
3.49
Quick ratio
2.6
Net debt/EBITDA
0.56
Margins
Efficiency
Dividend
EBITDA margin
33.2%
Gross margin
55.5%
Net margin
18.4%
Operating margin
22.6%
Return on assets
8.4%
Return on equity
15.1%
Return on invested capital
25.2%
Return on capital employed
13.6%
Return on sales
25.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HOLX stock price
How has the Hologic stock price performed over time
Intraday
0.26%
1 week
1.98%
1 month
-8.36%
1 year
-14.94%
YTD
-10.54%
QTD
-10.54%
Financial performance
How have Hologic's revenue and profit performed over time
Revenue
$4.04B
Gross profit
$2.24B
Operating income
$914.2M
Net income
$744M
Gross margin
55.5%
Net margin
18.4%
Hologic's operating income has surged by 55% YoY and by 3.4% QoQ
The operating margin has soared by 52% YoY and by 3.2% from the previous quarter
Hologic's net income has increased by 44% YoY but it has decreased by 6% QoQ
The company's net margin rose by 42% YoY but it fell by 6% QoQ
Growth
What is Hologic's growth rate over time
Valuation
What is Hologic stock price valuation
P/E
20.22
P/B
3.07
P/S
3.68
EV/EBIT
14.53
EV/EBITDA
11.34
EV/Sales
3.77
The EPS has surged by 50% year-on-year but it has declined by 4.8% since the previous quarter
The stock's price to earnings (P/E) is 28% less than its last 4 quarters average of 28.0 and 4.6% less than its 5-year quarterly average of 21.2
HOLX's price to book (P/B) is 27% lower than its 5-year quarterly average of 4.2 and 15% lower than its last 4 quarters average of 3.6
HOLX's equity is down by 7% since the previous quarter but it is up by 2.6% year-on-year
HOLX's price to sales (P/S) is 18% lower than its last 4 quarters average of 4.5 and 8% lower than its 5-year quarterly average of 4.0
Efficiency
How efficient is Hologic business performance
The ROE has grown by 48% YoY but it has contracted by 6% from the previous quarter
Hologic's return on assets has increased by 47% YoY but it has decreased by 7% QoQ
HOLX's return on invested capital is up by 40% year-on-year and by 5% since the previous quarter
The return on sales is up by 39% year-on-year and by 6% since the previous quarter
Dividends
What is HOLX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HOLX.
Financial health
How did Hologic financials performed over time
The total assets is 121% higher than the total liabilities
Hologic's quick ratio has decreased by 10% YoY and by 8% QoQ
Hologic's current ratio has decreased by 10% YoY and by 5% from the previous quarter
The company's debt is 47% lower than its equity
HOLX's equity is down by 7% since the previous quarter but it is up by 2.6% year-on-year
Hologic's debt to equity has increased by 6% from the previous quarter but it has decreased by 3.6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.